← Back
$KLRA All transactions

Kailera Therapeutics, Inc.

A

$ Value

$0

Shares

100,000

Price

$0

Filed

Apr 20

Insider

Name

Wasserman Scott M.

Title

Chief Medical Officer

CIK

0002118767

Roles

Officer

Transaction Details

Transaction Date

2026-04-16

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,000

Footnotes

The options vest and become exercisable as to 25% of the underlying shares on April 16, 2027 and thereafter in 36 substantially equal monthly installments, subject to the Reporting Person's continued service through each such vesting date. | The options vest and become exercisable, if at all, as to all of the underlying shares if (i) the average daily closing price of the Company's common stock on Nasdaq during any 30 consecutive calendar-day period during the period beginning October 16, 2026 and ending on April 16, 2030 (the "Performance Measurement Period"), or (ii) the stock price in a change in control transaction that occurs during the Performance Measurement Period, equals or exceeds $40 per share, in each case subject to the Reporting Person's continued service through such vesting date.

Filing Info

Accession No.

0001193125-26-164243

Form Type

4

Issuer CIK

0002096997

Wasserman Scott M.'s History

Date Ticker Type Value
2026-04-16 KLRA A $0
2026-04-16 KLRA A $0

Other Insiders at KLRA (90d)

Insider Bought Sold Last
Kaplan Andrew T. / BAIN CAPITAL INVESTORS LLC $134.4M 2026-04-20
Bain Capital Life Sciences Investors, LLC / Koppel Adam $25.0M 2026-04-20
RTW INVESTMENTS, LP $8.0M 2026-04-20
BAIN CAPITAL INVESTORS LLC 2026-04-20
MILLIGAN JOHN F 2026-04-16
Renaud Ronald C JR
CEO & President
2026-04-16
MACKAY MARTIN 2026-04-16
Koppel Adam 2026-04-20
Pagan Douglas W.
Chief Financial Officer
2026-04-16
Bain Capital Life Sciences Investors, LLC 2026-04-20
Burgess Paul D.
See Remarks
2026-04-16
Cloghessy Paula
Chief People Officer
2026-04-16
Kaplan Andrew T. 2026-04-20
Clyburn Frank 2026-04-16
Hite Christopher 2026-04-16
Akamine Scott
Chief Legal Officer
2026-04-16
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2026-04-20
Coleman Jamie Beth
Chief Commercial Officer
2026-04-16
Wasserman Scott M.
Chief Medical Officer
2026-04-16